WOLVERINE ASSET MANAGEMENT LLC - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 152 filers reported holding THERAVANCE INC in Q2 2013. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of THERAVANCE INC
ValueSharesWeighting
Q3 2015$12,000
-7.7%
116
-81.3%
0.00%
Q1 2015$13,000
-94.1%
621
-48.8%
0.00%
-100.0%
Q4 2014$220,000
+94.7%
1,213
+266.5%
0.00%
+100.0%
Q3 2014$113,000
+289.7%
331
+156.6%
0.00%
+100.0%
Q2 2014$29,000
+20.8%
129
+46.6%
0.00%0.0%
Q1 2014$24,0000.0%88
-35.3%
0.00%
Q4 2013$24,000
-80.3%
136
-71.2%
0.00%
-100.0%
Q3 2013$122,000
-32.6%
472
-62.3%
0.00%
-40.0%
Q2 2013$181,0001,2520.01%
Other shareholders
THERAVANCE INC shareholders Q2 2013
NameSharesValueWeighting ↓
Baupost Group 20,395,056$607,365,0009.89%
Realm Partners LLC 301,521$8,979,0003.75%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,805,837$83,558,0002.52%
IRIDIAN ASSET MANAGEMENT LLC/CT 7,447,743$221,794,0002.27%
SECTORAL ASSET MANAGEMENT INC 1,743,188$51,912,0002.20%
Foundation Asset Management, LP 255,790$7,617,0002.19%
Proxima Capital Management, LLC 550,000$16,379,0001.93%
Roundview Capital LLC 140,645$4,188,0001.69%
BB BIOTECH AG 933,244$27,792,0001.32%
PERRY CAPITAL 1,517,208$45,182,0001.25%
View complete list of THERAVANCE INC shareholders